Patent US4536501A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4536501A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted 4-phenoxy or 4-phenylthio prolines

Assignee: ER Squibb and Sons LLC
•
Filing: 1984-03-30
•
Granted: 1985-08-20
•
Expires: 2004-03-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula ##STR1## are disclosed. They possess angiotensin converting enzyme inhibition activity and diuretic activity and are therefore useful as antihypertensive agents.

Inventors

  • 👤 Joseph E. Sundeen
  • 👤 Rudiger D. Haugwitz
  • 👤 Peter W. Sprague

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 07:48
CPC Classifications
C; C07; C07D; C07D403/00; C07D403/02; C07D403/12; C07D207/00; C07D207/02; C07D207/04; C07D207/10; C07D207/16; C07D409/00; C07D409/14; C07D417/00; C07D417/02; C07D417/12; C07D417/14; C07F; C07F9/00; C07F9/02; C07F9/547; C07F9/6558; C07F9/65583; C07K; C07K5/00; C07K5/02; C07K5/022; C07K5/0222; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 338 words
A compound of the formula ##STR107## and a pharmaceutically acceptable salt thereof wherein X is oxygen or sulfur; --A 1 -A 2 -- is --CH--NH-- or --C═N--; A is ##STR108## p is one, two, three or four; R, R 8 and R 9 are independently selected from the group consisting of hydrogen, lower alkyl, benzyl, benzhydryl, and salt forming ion; R 1 and R 2 are independently selected from the group consisting of hydrogen, halogen, lower alkyl, lower alkoxy, halo substituted lower alkyl, nitro, and --SO 2 NH 2 ; Z is ##STR109## R 3 is hydrogen, lower alkyl, halo substituted lower alkyl, phenyl, benzyl, phenethyl or cycloalkyl; R 4 is hydrogen or ##STR110## R 5 is lower alkyl, ##STR111## n is zero, one, two, three or four; R 6 is hydrogen, lower alkyl, lower alkoxy, halogen, or hydroxy; R 7 is lower alkyl or cycloalkyl; R 10 is hydrogen, lower alkyl, ##STR112## halo substituted lower alkyl, hydroxy substituted lower alkyl, --(CH 2 ) q -cycloalkyl, --(CH 2 ) q -N(lower alkyl) 2 , --(CH 2 ) q --NH 2 , --(CH 2 ) q -carboxy, --(CH 2 ) q --SH, --(CH 2 ) q -S-lower alkyl, ##STR113## q is one, two, three or four; R 11 is hydrogen, lower alkyl, halo substituted lower alkyl, hydroxy substituted lower alkyl, --(CH 2 ) q --NH 2 , --(CH 2 ) q -N(lower alkyl) 2 , --(CH 2 ) q -quanidinyl, ##STR114## R 12 is alkyl of 1 to 10 carbons, ##STR115## cycloalkyl--(CH 2 ) m --; m is zero or an integer from 1 to 7; R 13 is hydrogen, lower alkyl, benzyl, benzhydryl, salt forming ion or ##STR116## R 15 is hydrogen, lower alkyl, cycloalkyl or phenyl; p0 R 16 is hydrogen, lower alkyl, lower alkoxy, cycloalkyl, phenyl, benzyl, or phenethyl; and R 14 is hydrogen, lower alkyl, cycloalkyl-(CH 2 ) n --, ##STR117## halo substituted lower alkyl, hydroxy substituted lower alkyl, --(CH 2 ) q --N(lower alkyl) 2 , or --(CH 2 ) q --NH 2 .
Claim 2
Dependent Claim 338 words
A compound of the formula ##STR107## and a pharmaceutically acceptable salt thereof wherein X is oxygen or sulfur; --A 1 -A 2 -- is --CH--NH-- or --C═N--; A is ##STR108## p is one, two, three or four; R, R 8 and R 9 are independently selected from the group consisting of hydrogen, lower alkyl, benzyl, benzhydryl, and salt forming ion; R 1 and R 2 are independently selected from the group consisting of hydrogen, halogen, lower alkyl, lower alkoxy, halo substituted lower alkyl, nitro, and --SO 2 NH 2 ; Z is ##STR109## R 3 is hydrogen, lower alkyl, halo substituted lower alkyl, phenyl, benzyl, phenethyl or cycloalkyl; R 4 is hydrogen or ##STR110## R 5 is lower alkyl, ##STR111## n is zero, one, two, three or four; R 6 is hydrogen, lower alkyl, lower alkoxy, halogen, or hydroxy; R 7 is lower alkyl or cycloalkyl; R 10 is hydrogen, lower alkyl, ##STR112## halo substituted lower alkyl, hydroxy substituted lower alkyl, --(CH 2 ) q -cycloalkyl, --(CH 2 ) q -N(lower alkyl) 2 , --(CH 2 ) q --NH 2 , --(CH 2 ) q -carboxy, --(CH 2 ) q --SH, --(CH 2 ) q -S-lower alkyl, ##STR113## q is one, two, three or four; R 11 is hydrogen, lower alkyl, halo substituted lower alkyl, hydroxy substituted lower alkyl, --(CH 2 ) q --NH 2 , --(CH 2 ) q -N(lower alkyl) 2 , --(CH 2 ) q -quanidinyl, ##STR114## R 12 is alkyl of 1 to 10 carbons, ##STR115## cycloalkyl--(CH 2 ) m --; m is zero or an integer from 1 to 7; R 13 is hydrogen, lower alkyl, benzyl, benzhydryl, salt forming ion or ##STR116## R 15 is hydrogen, lower alkyl, cycloalkyl or phenyl; p0 R 16 is hydrogen, lower alkyl, lower alkoxy, cycloalkyl, phenyl, benzyl, or phenethyl; and R 14 is hydrogen, lower alkyl, cycloalkyl-(CH 2 ) n --, ##STR117## halo substituted lower alkyl, hydroxy substituted lower alkyl, --(CH 2 ) q --N(lower alkyl) 2 , or --(CH 2 ) q --NH 2 .
Claim 3
Dependent Claim 236 words
A compound of claim 1 of the formula ##STR118## and a pharmaceutically acceptable salt thereof wherein R is hydrogen, lower alkyl of 1 to 4 carbons, or an alkali metal salt ion; R 14 is hydrogen or lower alkyl of 1 to 4 carbons; R 2 is halogen, lower alkyl of 1 to 4 carbons, or halo substituted lower alkyl of 1 to 4 carbons; R 4 is hydrogen or ##STR119## wherein n is zero, one or two; R 3 is lower alkyl of 1 to 4 carbons; R 8 is hydrogen, lower alkyl of 1 to 4 carbons, or an alkali metal salt ion; R 7 is lower alkyl of 1 to 4 carbons; R 9 is hydrogen, lower alkyl of 1 to 4 carbons, or an alkali metal salt ion; R 10 is ##STR120## wherein n is zero, one, two, three or four; R 11 is lower alkyl of 1 to 4 carbons, --CH 2 --S--(CH 2 ) 2 --NH 2 , or --(CH 2 ) 4 --NH 2 ; R 12 is alkyl of 1 to 10 carbons or ##STR121## wherein m is zero or an integer from 1 to 7; R 13 is hydrogen, alkali metal salt ion or ##STR122## R 15 is hydrogen, straight or branched chain lower alkyl of 1 to 4 carbons, or cyclohexyl; and R 16 is straight or branched chain lower alkyl of 1 to 4 carbons.
Claim 4
Dependent Claim 35 words
A compound of claim 2 wherein ##STR123## R 14 is hydrogen or methyl; R 2 is chloro or trifluoromethyl; R 4 is hydrogen or ##STR124## and R is hydrogen or an alkali metal salt ion.
Claim 5
Dependent Claim 22 words
A compound of claim 3 wherein R 4 is ##STR125## R 14 is hydrogen; R 2 is chloro; and R is hydrogen.
Claim 6
Dependent Claim 6 words
The compound of claim 4, (S)-4-[4-[[7-(aminosulfonyl)-6-chloro-3,4-dihydro-1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl]methyl]phenoxy]-1-[(S)-3-(benzoylthio)-2-methyl-1-oxopropyl]-L-proline.
Claim 7
Dependent Claim 22 words
A compound of claim 3 wherein R 4 is hydrogen; R 14 is hydrogen; R 2 is chloro; and R is hydrogen.
Claim 8
Dependent Claim 6 words
The compound of claim 6, (S)-4-[4-[[7-(aminosulfonyl)-6-chloro-3,4-dihydro-1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl]methyl]phenoxy]-1-[(S)-3-mercapto-2-methyl-1-oxopropyl]-L-proline.
Claim 9
Dependent Claim 22 words
A compound of claim 3 wherein R 4 is ##STR126## R 14 is hydrogen; R 2 is trifluoromethyl; and R is hydrogen.
Claim 10
Dependent Claim 6 words
The compound of claim 8, (S)-4-[4-[[7-(aminosulfonyl)-3,4-dihydro-1,1-dioxo-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazin-3-yl]methyl]phenoxy]-1-[(S)-3-(benzoylthio)-2-methyl-1-oxopropyl]-L-proline.
Claim 11
Dependent Claim 22 words
A compound of claim 3 wherein R 4 is hydrogen; R 14 is hydrogen; R 2 is trifluoromethyl; and R is hydrogen.
Claim 12
Dependent Claim 6 words
The compound of claim 10, (S)-4-[4-[[7-(aminosulfonyl)-3,4-dihydro-1,1-dioxo-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazin-3-yl]methyl]phenoxy]-1-[(S)-3-mercapto-2-methyl-1-oxopropyl]-L-proline.
Claim 13
Dependent Claim 22 words
A compound of claim 3 wherein R 4 is ##STR127## R 14 is methyl; R 2 is chloro; and R is hydrogen.
Claim 14
Dependent Claim 6 words
The compound of claim 12, (S)-4-[4-[[7-(aminosulfonyl)-6-chloro-3,4-dihydro-2-methyl-1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl]methyl]phenoxy]-1-[(S)-3-(benzoylthio)-2-methyl-1-oxopropyl]-L-proline.
Claim 15
Dependent Claim 22 words
A compound of claim 3 wherein R 4 is hydrogen; R 14 is methyl; R 2 is chloro; and R is hydrogen.
Claim 16
Dependent Claim 6 words
The compound of claim 14, (S)-4-[4-[[7-(aminosulfonyl)-6-chloro-3,4-dihydro-2-methyl-1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl]methyl]phenoxy]-1-[(S)-3-mercapto-2-methyl-1-oxopropyl]-L-proline.
Claim 17
Dependent Claim 46 words
A compound of claim 2 wherein A is ##STR128## R 8 is hydrogen, ethyl, or an alkali metal salt ion; R 7 is ethyl; R 14 is hydrogen or methyl; R 2 is chloro or trifluoromethyl; and R is hydrogen or an alkali metal salt ion.
Claim 18
Dependent Claim 50 words
A compound of claim 2 wherein A is ##STR129## R 9 is hydrogen, ethyl, or an alkali metal salt ion; R 10 is ##STR130## R 11 is methyl; R 14 is hydrogen or methyl; R 2 is chloro or trifluoromethyl; and R is hydrogen or an alkali metal salt ion.
Claim 19
Dependent Claim 76 words
A compound of claim 2 wherein A is ##STR131## R 12 is ##STR132## R 13 is hydrogen, alkali metal salt ion, or ##STR133## R 15 is hydrogen, straight or branched chain lower alkyl of 1 to 4 carbons, or cyclohexyl; R 16 is straight or branched chain lower alkyl of 1 to 4 carbons; R 14 is hydrogen or methyl; R 2 is chloro or trifluoromethyl; and R is hydrogen or an alkali metal salt ion.
Claim 20
Dependent Claim 55 words
A composition useful for treating hypertension comprising a pharmaceutically acceptable carrier and an effective amount of a hypotensive agent or pharmaceutically acceptable salt thereof of the formula ##STR134## wherein A, --A 1 -A 2 --, R, R 1 , R 2 , R 14 , p, X, and Z are as defined in claim 1.
Claim 21
Dependent Claim 21 words
The method of treating hypertension in a mammalian specie which comprises administering an effective amount of the composition of claim 19.
Claim 22
Dependent Claim 32 words
A compound of the formula ##STR135## wherein --A 1 -A 2 --, p, R, R 1 , R 2 , R 14 , X and Z are as defined in claim 1.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-08-19 1989-02-18 1989-08-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-08-19 1993-02-18 1993-08-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-08-19 1997-02-18 1997-08-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag